CALITHERA BIOSCIENCES INC's ticker is CALA and the CUSIP is 13089P101. A total of 2 filers reported holding CALITHERA BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $863,000 | -54.7% | 2,136,775 | -25.3% | 0.00% | – |
| Q4 2021 | $1,904,000 | -70.3% | 2,861,596 | -2.5% | 0.00% | – |
| Q3 2021 | $6,401,000 | +4.2% | 2,936,308 | -0.1% | 0.00% | – |
| Q2 2021 | $6,141,000 | -31.5% | 2,938,187 | -20.6% | 0.00% | – |
| Q1 2021 | $8,960,000 | -50.3% | 3,702,517 | +0.8% | 0.00% | -100.0% |
| Q4 2020 | $18,043,000 | +47.1% | 3,674,694 | +3.3% | 0.00% | – |
| Q3 2020 | $12,269,000 | -28.9% | 3,555,945 | +8.8% | 0.00% | -100.0% |
| Q2 2020 | $17,261,000 | +58.3% | 3,268,891 | +33.1% | 0.00% | – |
| Q1 2020 | $10,906,000 | -17.8% | 2,456,268 | +5.7% | 0.00% | – |
| Q4 2019 | $13,271,000 | +84.3% | 2,324,207 | -0.3% | 0.00% | – |
| Q3 2019 | $7,202,000 | -12.6% | 2,330,657 | +10.3% | 0.00% | – |
| Q2 2019 | $8,242,000 | -23.4% | 2,113,189 | +32.3% | 0.00% | – |
| Q1 2019 | $10,766,000 | +83.7% | 1,597,220 | +9.3% | 0.00% | – |
| Q4 2018 | $5,860,000 | -13.6% | 1,461,263 | +13.1% | 0.00% | – |
| Q3 2018 | $6,781,000 | +10.7% | 1,291,646 | +5.4% | 0.00% | – |
| Q2 2018 | $6,128,000 | -17.4% | 1,225,712 | +4.1% | 0.00% | – |
| Q1 2018 | $7,418,000 | -20.1% | 1,177,416 | +5.9% | 0.00% | – |
| Q4 2017 | $9,287,000 | -46.4% | 1,112,175 | +1.1% | 0.00% | -100.0% |
| Q3 2017 | $17,324,000 | -2.7% | 1,099,931 | -8.3% | 0.00% | 0.0% |
| Q2 2017 | $17,813,000 | +66.7% | 1,199,525 | +29.7% | 0.00% | 0.0% |
| Q1 2017 | $10,684,000 | +609.9% | 925,015 | +99.8% | 0.00% | – |
| Q4 2016 | $1,505,000 | +10.7% | 462,878 | +10.7% | 0.00% | – |
| Q3 2016 | $1,360,000 | -14.9% | 418,324 | -2.9% | 0.00% | – |
| Q2 2016 | $1,598,000 | -37.2% | 430,622 | -3.9% | 0.00% | – |
| Q1 2016 | $2,544,000 | -23.3% | 447,867 | +3.4% | 0.00% | – |
| Q4 2015 | $3,318,000 | -98.1% | 433,195 | -91.9% | 0.00% | -100.0% |
| Q3 2015 | $173,837,000 | +8618.0% | 5,379,866 | +1826.7% | 0.01% | – |
| Q2 2015 | $1,994,000 | -53.8% | 279,224 | +6.2% | 0.00% | – |
| Q1 2015 | $4,317,000 | -2.9% | 262,880 | +19.5% | 0.00% | – |
| Q4 2014 | $4,444,000 | – | 219,987 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,426,702 | $5,290,000 | 3.82% |
| BVF INC/IL | 7,452,331 | $16,246,000 | 0.63% |
| TSP Capital Management Group, LLC | 661,600 | $1,442,000 | 0.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 186,245 | $406,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 525,667 | $1,146,000 | 0.12% |
| Parkman Healthcare Partners LLC | 100,628 | $219,000 | 0.06% |
| FEDERATED HERMES, INC. | 6,668,978 | $14,539,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 133,700 | $291,000 | 0.02% |
| Ergoteles LLC | 274,805 | $599,000 | 0.02% |
| Seelaus Asset Management LLC | 16,150 | $35,000 | 0.02% |